Insider Buying: Neonc Technologies (NASDAQ:NTHI) CEO Acquires $49,860.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour bought 9,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were acquired at an average cost of $5.54 per share, with a total value of $49,860.00. Following the completion of the transaction, the chief executive officer owned 3,096,000 shares in the company, valued at approximately $17,151,840. The trade was a 0.29% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Neonc Technologies Trading Down 1.5%

NASDAQ NTHI opened at $4.56 on Friday. Neonc Technologies Holdings, Inc. has a one year low of $3.01 and a one year high of $12.99. The business’s fifty day moving average is $4.14 and its 200-day moving average is $5.95.

Neonc Technologies (NASDAQ:NTHI) last issued its quarterly earnings results on Monday, August 10th. The company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.46).

Institutional Trading of Neonc Technologies

A number of hedge funds and other institutional investors have recently bought and sold shares of NTHI. Bank of America Corp DE grew its position in shares of Neonc Technologies by 1.0% during the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock valued at $2,056,000 after purchasing an additional 2,207 shares in the last quarter. State Street Corp raised its position in shares of Neonc Technologies by 9.9% in the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after buying an additional 3,900 shares in the last quarter. Barclays PLC raised its position in shares of Neonc Technologies by 5,314.8% in the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after buying an additional 8,982 shares in the last quarter. Goldman Sachs Group Inc. bought a new stake in Neonc Technologies during the fourth quarter valued at $124,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Neonc Technologies during the fourth quarter valued at $126,000.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Alliance Global Partners started coverage on shares of Neonc Technologies in a research note on Tuesday, May 19th. They issued a “buy” rating and a $13.00 target price on the stock. Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. BTIG Research reiterated a “buy” rating and issued a $15.00 price objective on shares of Neonc Technologies in a research note on Tuesday, May 26th. Wall Street Zen lowered Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Finally, Maxim Group started coverage on Neonc Technologies in a research report on Monday, May 18th. They issued a “buy” rating and a $20.00 target price for the company. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $16.00.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.